with the mrna vaccinend itself. >> right. before we move on to far i want to ask what you're saying about talking about some of the other innovations you brought up which brings me too my next question. can you talk about how mrna could be used for things like cancer or other diseases? >> there's a lot of interest now in the pharmaceutical industry, and gene therapy and correcting diseases by making changes to dna. that can either be editing or providing genes that are absent. so there are a number of ways to do that. there are viral delivering vehicles and others. mrna also is a very interesting way to deliver genes. we have the current viral vectors. could have relatively small genes that's a challenge the other challenge is how you deliver specific genes to specific cell types and not all cell types. those are some of the challenges was some select activity and delivery. and perhaps even further. >> i think something you have interest in, the research and develop structure itself. what havets you learned about new scientif

vaccines, mrna covid vaccines need to be withdrawn from the market. no one should get them. no one should get boosted. no one should get double boosted. they are a dangerous and ineffective product at this point against omicron despite they make your body make that you -- it's not the omicron spike. earlier today tony fauci said we're not going to give people mono cleanly antibody first generation products because they don't work against the omicron spike. the same logic applies to these mrna vaccines and giving people boosters, even in the very short term, knocks down infection rates there is a boomerang effect and that's what they are seeing in all of these countries. we're at dangerous moment and these products need to be withdrawn. >> tucker: you say they are ineffective and that's demonstrable to anybody who lives in this country. anyone who has had covid, most of them are fine but when you say they are dangerous, what do you mean by that? >> there was a jama paper today that shows rates of myocarditis, which is a heart inflammation that can be v

those are some of the challenges, and mrna good address --mrna could address some of those challenges on selectivity and delivery. caitlin: something you have interest in is the research and development structure itself. what have we learned about finding new scientific innovations, and then the next step, bringing those to market for actual use? dr. schultz: the interesting thing when the pandemic started, there was a huge focus of the scientific community on sars-cov-2. it was almost like a manhattan project. everybody turned their attention to how we deal with this, how do we understand the virus and the biology of the virus and the structure of the virus? how do we make new antivirals? how do we monitor transmission of the disease, and how do we make new therapeutics, either as antivirals or as vaccines? i think that was a very interesting case of the entire scientific community turning its attention to a major health problem. and along with that came a huge increase in speed in which you could test new therapies and get emergency use authorization of new therapies. i think you co

can you talk about how mrna can be used for things like cancer or other diseases?of interest now in the pharmaceutical industry in gene therapy and correcting diseases by making changes to the dna and that can be editing out mutations in dna or providing genes that are absent or the fact that where the deficits lead to disease so there are a number of ways to do that. there are viral delivery vehicles, mrna represents a really interesting way to deliverre genes. the current viral factors are limited by cargo so you can only deliver relatively small genes and that's a major challenge in the field. the other challenge in the field is how you deliver specific gegenes to specific cell types d not all cell types. those are some of the challenges and mrna could actually address potential some of those challenges for delivery selectivity perhaps even further. >> i think something you've been interested in is the research and development structure itself, what have we learned about finding new scientific innovations and step of bringing those to market for actual use? >> i

especially on mrna vaccines. more than j&j. but there is no reason to believe, given the parallel protection we have seen, with j&j, boosted. or with mrna that is boosted, as well as the mix-and-match, which has been done, where you can vaccinate with one platform and boost with the other, it is very interestingly, it works quite well. they do booch each other -- boost each other rather well. in the situation with mrnas, it is quite parallel with the boosted jna. at the first dose, but the boosted j&j. >> let's go to cheyenne at abc. >> thank you. dr. fauci, i had a question for you. could you talk a little bit about the next age group waiting for vaccines for kids four and younger. you have any update on what we will hear from pfizer, and data. i think you talked about that coming in the next month. could you clarify. the vaccine, and when it will be expected to be sufficient, and with covid, do you think the rollout for patients is going well, or will there be other things the government can do to make it easier to obtain. >>

welcome kizzmekia corbett pictures a viral immunologist key scientist behind the invention of the mrnand professor at the school of public health. welcome to "washington post" life. saying thank you so much for having me and happy new year. >> happy new year to you too. let me start with the news of the day if i may. we have a record-breaking million cases out there and president biden has called for increased testing and doubling the number of anti-viral pills available and a state of emergency now with the increasing number of hospitalizations. what is your take on the possibility of this new variant? >> i call it the oh my. variant instead of the omicron variant. just to make a little bit fun of it even though it is not fun to be experiencing this at all. variants are coming because we are allowing the virus to circulate around the globe continuously so as the virus circulates the virus makes copies of itself and it makes copies of itself and anyway it's possible for the virus to come back around and cause more harm. in the case of omicron obviously it's better at being transmittabl

it doesn't use the mrna technology. andrew: i'm glad you brought that up, because what you are referring there is from baylor college that talk to them both about this pandemic as far as this being a remarkable deal as far as what they have been doing down in texas and dulling their own vaccine. they were working on sars back in 2003 trying to develop a vaccine back then. one of my first topic -- conversations was with maria in 2020. denting to get funding back then . once the pandemic -- it is pretty amazing 20 years later they stuck to it. i think the vaccine is called covax now -- we will see how far that makes it around the world and it is encouraging as far as they have a massive indian manufacturer behind that to mass-produce it and we should have a big impact on low and middle class countries. we don't hear about it much in the u.s. because those trial results came out maybe a month or two ago, so it is a little behind those early efforts from pfizer, modernity, j&j, astrazeneca. they don't have a big pharma back

why are so many choosing the non-mrna? is it supply?ly and it's actually interestingly geopolitics. china has gone to other countries and built 15 factories. russia sent -- the russian vaccine has had a lot of production problems. the chinese vaccine has been produced. billions have received it. it has efficacy problems. it does not work as well as the mrna vaccines that we are making here in the united states. the question is, well, can we make more of those mrna vaccines? yes. we can scale production in the united states. we can increase production. the nih moderna vaccine, the one you referred to earlier, they created a plant and had it up and running in new hampshire in a matter of four months. it creates 1 billion vaccines. you can imagine that you could create two or three or four other such plants in the united states in short order. it would be an american product. it would give more american jobs. you could supply the world with vaccine. you could build vaccine plants in other places as china has done or support other countries

the mrna is transient, so you want to have a permanent therapy after delivering the mrna.en idea is the vaccine, you create permanent protection from the vaccine. the other is gene editing, where we will deliver a little bit of the mrna with an editor and it, and as a result we will permanently change the dna and give you potential a lifelong benefit. so they looked at the whole landscape and shows the technology we are looking at, called base editing, so they called us and we could not have been happier with the conversation, and from there the deal went very fast. guy: good morning. i will add my congrats. let's talk a little bit about how that initial conversation went. when that conversation happened, was it we would like to partner with you, or let's discuss a range of options, one of which is a partnership, one of which may in acquisition? as we heard a little earlier, just a few moments ago, maybe from a pfizer point of view, the most efficient way is a partnership, but was in acquisition ever discussed? john: we did discuss a range of different options. i think ult

my understanding is it doesn't use the mrna technology. it could be mass produced by a bunch of different countries. it was approved in india. apparently, they could not get funding like pfizer did for the mrna. they had to do research and development on a small amount of money. host: what was the name of the antivirus? caller: it came out of texas university. it was approved in india. they are starting production on that. it doesn't use the mrna technology. it could be produced anywhere in the world. guest: i'm glad you brought that up. you are referring to baylor university. i talked to them throughout the pandemic in terms of what they've been doing in texas. they've developed their own vaccine. they're working on sars in 2003, trying to develop a vaccine then. that was when my first conversations about those efforts in 2003. they were attempted to get funding 20 years ago. when the pandemic subsided, funding also evaporated. it's pretty amazing. they stuck to it. they did authorize it under conditional approval. we will see how far it

we had the you know, the success of the mrna platform, which had been underdevelopment for you know a dream for 20 years 30 years under development at moderna for 10 toning everything from sort of this lipid that the mrnas packaged in to how you actually get your in this mrna vaccine these gen instructions into the body cells where they can stimulate the immune system just right to create that response. we need to so we can develop antibodies. i mean this all the step was just kind of like on tap the moment the pandemic broke out how i mean if this had happened a year or two earlier, we would be it was still waiting i think and then the second thing was we're kind of lucky that it was a coronavirus coronavirus small group of people admittedly. who'd seen the first stars outbreak 20 years ago, and then also were watching what was happening with what's there? were these other related coronavirus syndrome and this is a lot of research was going into understanding these viruses manipulating them and realizing that the spike of the coronavirus to go for and that was already to go right the

expanding the mrna effort. understand why the partnership instead of straight acquisitions? albert: sometimes being a good partner provides better results than your own company. right now we want to place multiple bets. we have proven this works very well. i would not say it you do not see acquisitions, but in these specific areas we have found's partnerships give us what we want without capital meeting. -- jonathan: what does that mean for capital allocation elsewhere if the strategy is a series of bets -- albert: clearly the number two priority is to invest a lot of capital allocation, either through the normal course of business or through covid. that needs to be an investment in science. -- we have a developed machine. all of these platforms -- jonathan: let's talk about the platform getting the most attention. it has been meant with hope, confusion, and skepticism. i'm trying to understand how you communicate the hope around this when we keep getting told we needed of that shot. if it is so good, why do i

it is not mrna, it is related to the virus.u ask experts, the natural infection with this virus also doesn't produce immunity. the natural infection many times produces half the time you can get in terms of how long you are protected then vaccines. it is not right to say mrna doesn't create durable protection. it is the virus that is very difficult to tackle and mutates constantly. emily: albert bourla there. meantime, bayer and mammoth biosciences have announced a partnership to use mammoth's crisper gene editing technology. joining me now, trevor martin of mammoth biosciences. how do you and bayer plan to work together? trevor: we are excited about this collaboration because at mammoth we have built a broad toolbox of novel crispr systems, including small proteins. this collaboration with bayer is all about expanding gene therapy platforms with novel crispr proteins that can enable en viva therapies. emily: you are focused on four diseases, all liver based. why those and where do you hope to expand? trevor: liver is the start

mrna there it is. she's down 7.2% for the week down almost 13 that's mrna. true shares technology, down 12%. and vannic digital transformation down about 13%. a.i. and deep learning etf, its holdings include some of the software names we talked about this week, like data dog and crowd strike, and vaneck, investigators digital transformation etf this one focused on crypto its top holding include coinbase, micro strategy, rye roe yot and marathon the data come from our partners at the financial times and its wilshire etf hub mrna. >> how can i not think of that every time i see mrna now. >> malls and retail were hit hard throughout the pandemic, but kimco seems to be making a comeback jumping 63% over the past year will omicron hurt the coryreve the ceo weighs in next new year, new start. and now comcast business is making it easy to get going with the ready. set. save. sale. get started with fast and reliable internet and voice for $64.99 a month with a 2-year price guarantee. it's easy... with flexible installation and backing from an expert team, 24/7. and

the platform we talk about right now is the mrna. the vaccine immunogen is that protein in its pre-fusion stabilized form. here are two examples of what is going on now. for example, a number of groups have used the nano particle approach which is the platform. the immunogen of the spike fragments that were put in the vaccine would lead to a diverse antibody response, hence covering a broader array of a particular virus. another example is an inactivated whole virus vaccine where you have different versions of the coronavirus delivered by an intranasal mix. this is important because this can go a long way to protecting against infection and spread of infection. i use those two examples because they are two of many that are currently being produced. next slide. the final slide is some key points. i do not want anyone to think that the pan coronavirus vaccine is around the corner in a month or two. it will take years to develop. >> we will take you live to a discussion on geopolitical threats in 2022. we join us live in progress here o

is that the key, china's introduction of its own mrna? as health secretary and a doctor, what does science tell you about that? >> in hong kong we have two vaccines available for our people. one is sinovac, the inactivated virus platform, and the other is mrna, the biontech. about 60% of people are taking biontech and 40% are taking sinovac. our experts have told us both vaccines are effective in protecting oneself, if you are being infected, then you are protected from severe symptoms as well as the risk of dying would be lower and going to icu would be lower. stephen: in your dialogue with china -- we are talking about the border, international flights, and a minute. what's the latest on the border? we are in the middle of a wave, the olympics about to start. are you getting any indication that china will be open -- will be able to open the border with hong kong soon? >> we have been trying to discuss through our communication channels with china about resuming quarantine free travel between hong kong and china. the work is ongoing. of

an enormous pleasure to welcome a viral immunologist, a key scientist behind the invention of the mrna vaccine. a very warm welcome. >> thank you so much for having me. happy. -- happy new year. >> let me start with the news of the day. we have a record-breaking number of cases out there, president biden has called for increased testing. in maryland we have an increasing number of hospitalizations. maybe you can give me your take on omicron and the possibility for new variants. >> i call it the oh my gosh variant. [laughter] we are allowing the virus to circulate around the globe continuously. in the case of omicron, you are seeing it being more transmittable, there is some evasion of pre-existing immunity whether from prior infection or vaccine responses. because of that, we are seeing record numbers of cases. the interesting thing and most important part of it is just like with the previous variance, largely the vaccine is keeping people safe from severe illness. as we are seeing people flooding the emergency rooms and people ending up in the icu, it's important to be vaccinated, get

so the mrna act seemed don't work, is mrna technology completely worthless?rk. we have to get through this confusion and be really clear. number one, we have under vaccinated the world so when the who who's been asleep at the switch for a lot of the pandemic says we can't keep boosting and boosting, they are different making different points, a lot of the world is not even vaccinated and less than 10% of the people in africa are vaccinated that's for the latest variant omicron spun out. the variant then got through our immune defenses, we are making a lot of mistakes here in the u.s., the biden administration. number one, they are not counting immunity from previous infections and they should. if somebody just got over covid like you did, i don't even want you to have a shot and i think your protected. it's about time they say so. in terms of boosters, i think the boosters work at decreasing severity especially if you are in a high risk and elderly, especially if you have obesity or pre-existing condition, keeps you out of the hospital 90% of the time comes o

getting back to the pandemic briefly, these mrna vaccines, there's basically the desired in the mrna vaccine a month into the pandemic getting up and going with previous arbitration the timeframe they did was extraordinary success. in terms of the dedication to issues of equity, we have these forces so 85% of patients come from outside of this area many of whom have acute with leukemia, no immune system, save the child's life and it's like great, here's what we need to do is everybody in the family vaccinated? 30% of the timeve, no and having the conversation is challenging, it's possible but a challenge so we are talking about lack of understanding in these circumstances that i thinkwh isa challenge but the pandemic hast made completely clear. >> when we look at what's happened during the pandemic -- introduction -- that is a result of this -- we also want to highlight focusing on those in society. >> the outcomes from effects such rate points, it's extraordinary wires what they do at universities haven't quite figured that out yet. based on this, you have to get universities to bio

it does not related to mrna. it is related to the virus.you know, the natural infection of this virus also doesn't produce immunity. the natural infection in many times produces half the time you can get in terms of how long you are protected. then the vaccines. so it is not right to say mrna doesn't create protection. it is the virus that is difficult to tackle. rishaad: news out of china, that concerns a city that is seen as beijing's port, with 14 million people. the city imposing a partial lockdown in a particular district because of a covid outbreak taking place apparently there. that is coming through at the moment. china added 110 local concerned cases and a covid flareup in another area as well. that is the latest, china saying they haven't planned to adjust the olympics covid measures for the time being. we will keep our eyes on that. we will move to business flash headlines. a financial group is set to name a new chief executive. if approved at a board meeting, he will replace an executive who announced his regulation -- his resig

she sat down with "the washington post" to discuss the future of mrna vaccines such as the vaccines producedy pfizer and moderna. ♪

the technology that mrna technology -- th is world changing, lifesaving technology and am personallyrateful i have been vaccinated, that i had been boosted, that one of my two kids has been vaccinated. i am really looking forward to my two-year-old being vaccinated. i am incredibly grateful for that technology. the second thing i would say, however, is use that enormous profits, right, the estimated profit revenues that moderna is going to bring in 2022 is between $15 million and $18 billion. use that amazing profit to change the world. so this vaccine isn't just a privilege for people in rich countries, but is truly part the global effort to get as out of the pandemic nightmare. because at current rates of production, moderna' current rates of production which they're keeping deliberately low, we're going to be in this pandemic nightmare for many years to come. but they have the ability to partner with other manufacturers to license our technology to other manufacturers, to work with the who in order to dramatically scale up production. and that is really our only way out of this pa

. >> they have received two of the mrna shots . >> we're going to try to convince them why it's important to get vaccinated. i think getting the data available to them, to show them how profoundly important it is to get boosted, the data, the truth speaks for itself. it makes the protection go from rather low to way up to 90% for hospitalization. i think people could be much more enthusiastic about getting their booster shot. >> just this morning the pfizer said the ceo hoped for a yearly shot than booster. what is your assessment on that? >> it's too early to tell. one of the things we need to find out for sure is what the durability of protection against the third dose of an mrna and second dose of the j&j. it's natural for the antibodies to go down, but there are things that aren't easily measurable, to look at the level of the memory response, both memory b-cells that make antibody and t-cells that give you durable protection. if that goes out for a longer period of time, that will determine how often you need to get boosted. i don't think one can project that right now until we get t

they know that and they are catching up with mrna vaccines but their population is not protected andwill see if they can use this zero covid approach to handle the arrival of all these people. lisa: dr. beyrer, there is a tension. the amount of time it takes to create a vaccine that targets the omicron variant and distributed in the population before you see outbreaks out of control in china. where is a vaccine the targets omicron and do you see that working out for china? dr. beyrer: the omicron-specific vaccines are not ready. they are under development and will not see them in any timeframe that will have an impact on the olympics. however, the high efficacy vaccines like the mrna vaccines, the j&j vaccines, with boosting are showing robust protection against severe disease, hospitalization and death with omicron. what they are not able to do is dramatically reduce acquisition and transmission. that is why we are seeing so many breakthroughs in fully vaccinated people. it is not those folks who are ending up in the hospital. what china needs to do is catch up with high efficacy va

booster shots with mrna vaccines failed to block omicron in a study of the first rank through cases.- rick through cases. all of the cases studied were mild or moderate providing support for the extra shots ability to prevent disease, death, and hospitalizations. global news 24 hours a day on air and on bloomberg quicktake. powered by more than 2700 journalists and analysts in over 120 countries. i'm mark crumpton. this is bloomberg. >> welcome to bloomberg markets. matt: u.s. stocks erased declines and a choppy session as volatility returns. turbulence in the airlines, a 5g rollout by at&t and verizon airports could interfere with safety systems leading to disruptions and cancellations. so far, we have a slight reprieve and we have not seen many disruptions or cancellations. a new study shows that booster shots with mrna failed to block omicron and early documented breakthrough cases. all that and more coming up. >> i thought you will characterized it talking about the choppy session we have seen. a little bit of green on the screen when it comes to north american markets, but there

. >> just touched on this, it's morgan, there are the mrna and viral vector vaccines on the market herenovavax is a protein based vaccine which is a technology or based on a technology around for much longer, you said you expect there to be a lot of demand here in the u.s. and globally where do you expect that demand to come from when you do have countries like here in the u.s. or in case of israel, tripling down even quadrupling down the technologies >> right well we have boosters so as i say three markets, there's been a -- the pediatric market which is a very large market, there's been some hesitancy about recommending the mrnas for people under 30, for instance, and i don't think, you know, so that's a market that we can go to we've got good boosting data against people who have been hesitant, that could be used for people who have been hesitant for just because they don't understand mrna vaccines and they do think they have more confidence in ours, and i think there's also, remember, there's 30% of the u.s. population that hasn't been vaccinated now we're not going to get all of th

calling on spotify to censor joe rogan show specifically because he featured that the inventor the mrna platform dr. robert malone. today he is here to respond. since i'm hosting, we needed somebody to fill the friday follies void. thankfully actor and director robert dobbie stepped up and we have video of an unhinged director that you will not believe. get your space helmets and stay for that. but first of all, there is a new poll that caught my attention. it claims that 58% of americans believe democracy is in danger of collapse. collapse! i can see why they might think that. i'm not talking about the media fuel that january 6 narrative or a band of goofballs broke windows of the capital. citizens obnoxious trance. trespassing's are not a threat to the democracy. otherwise the doj would have a task force tracking down the rioters as well. the real threat is the one the founders identified appeared to an tyrannical government that forces its will on citizens. regardless of what the constitution says. a good example is the biden administration's push to secure what it calls voting right

will also be there who pioneere mrna technology. thank you so much for coming on doctor.d to say unabashedly, i' glad this is finally happening. why are you joining us? >> tucker, thank you so much fo the opportunity to be there. i am joining because i'm a scientist, i'm committed to this , and i'm committed to medical ethics. unfortunately, we politicize th situation and we didn't need to. we really should have been focusing on the science and now the science is making it clear. they are not effective at blocking the transmission of th virus, they don't stop you from being infected, there is no reason that the mandates should be forcing vaccination on people . i'm not against vaccination, i spent 30 years as a scientist i as a physician developing vaccines including the core technology that gave rise to these mrna vaccines. it is clear now that the scienc is settled and it no longer mak sense to force these vaccines onto people. >> i thought that we had a kind of consensus on that. i thought american physicians agreed that the compulsory medical care was unethical, it wa

my understanding is it doesn't use the mrna technology.could be mass produced by a bunch of different countries. it was approved in india. apparently, they could not get funding like pfizer did for the mrna. they had to do research and development on a small amount of money. host: what was the name of the antivirus? caller: it came out of texas university. it was approved in india. they are starting production on that. it doesn't use the mrna technology. it could be produced anywhere in the world. guest: i'm glad you brought that up. you are referring to baylor university. i talked to them throughout the pandemic in terms of what they've been doing in texas. they've developed their own vaccine. they're working on sars in 2003, trying to develop a vaccine then. that was when my first conversations about those efforts in 2003. they were attempted to get funding 20 years ago. when the pandemic subsided, funding also evaporated. it's pretty amazing. they stuck to it. they did authorize it under conditional approval. we will see how far it make

robert malone the scientist behind the mrna vaccine platform. he was on the show a few weeks ago.what he told us turned out to be exactly right. over the last two weeks, covid cases have shot up 204%, but deaths are down 3%. omicron is not the disaster of the so-called experts told us it would be so big tech is swooping in, of course, to build them all out. last wednesday they banned dr. malone for repeated violations of covid-19 misinformation policy. now "gutfeld!" asked what host it deemed problematic and they would not tell us. so we asked dr. malone. he didn't know either. the very next day, malone went on joe grogan's podcast where he calls out the medical establishment for the push for control and in doing so through disturbing parallels between what is going on now versus 100 years ago. >> what the heck happened in german in the 20s and 30s? very intelligent highly educated population and they went barking mad. and how did that happen? the answer is misinformation psychosis. when you have a society that has become decoupled from each other and has free-floating anxiety and

right now optimal protection is with a third shot of mrna or second shot of j&j.nedy: then wire their breakthrough infections? how long before we get vaccine punchcards? nine shots, discrete. let's get in to tonight's party panel, karol markowicz attorney and democrat strategist, kelly hyman and for medium and host of the part of the problem podcast dave smith is back with us. carol, i will start with you, it's a must at some time, it's become meaningless. >> at sometimes none of us will be vaccinated, up-to-date as factory prescribed. the thing is the mandate make less sense in a situation like that. i get my flu shot will disappear, some years i get busy and don't have the time and the idea couldn't eat inside a restaurant the year i don't is absurd and the fact that we've seen with omicron the vaccine does not prevent you from getting and spreading the virus, what are we doing here? why are we forcing people into this? it makes no sense to me and fauci has been the worst spokesperson this entire time, he should not be on our televisions, if joe biden wants to f

austin wears a welding helmet with a surgical mask underneath and underneath that there's as much mrna in his bloodstream as the law will allow. lloyd austin is ready to wage a protracted siege against covid. think of the romans, -- and yet somehow in some way a change must have appeared in his formidable armor. yesterday lloyd austin announced that despite his many vaccinations, he has contracted covid and it's serious enough you won't be going to work for a while. so what's the lesson that lloyd austin is taken from ischemic if the vaccines work perfectly and because they work so well, they will remain mandatory in the armed services, we can fire more seals. austin wrote that in the same statement in which he announced that the vaccine that he took didn't work. "the vaccines work and will remain a military medical requirement for a workforce." right, because that's not completely irrational or anything. but it is completely irrational, and every clear thinking person knows that it is. but wait, you say, i've been watching television news, so i know that the vaccine was never designed

without spinning the message that people had gotten to doses of mrna vaccine or one dose of j&j were not fully immunized. we had an excellent vaccine that has excellent protection against the risk including delta variant and all age groups right up to the present time but you would never know by the way is communicated because everybodydy is scurrying to cash in on the booster palouse is that we created that we scared people and created a third dose fever. if you really want to get on top of the pandemic that is not the issue. i tell you the university of pennsylvania and philadelphia when adults come into hospital and are in the intensive care unit is not that they haven't got the third doses because they haven't got any doses in until we get on top of that it will make a major impact on this pandemic. >> i share your perspective on those issues. >> sometimes it's hard to pull back and see the forest from the trees. but if a new disease emerged today that had the hospitalization and mortality rate of vaccinated people we would not shut the world down for that. i think those are impo

two german researchers invented a vaccine based on the new mrna technology that help to save millions of lives around the world. these examples are proof of the power of cooperation for they also illustrate the importance of exchanges like the one we are having here today. i was in 2000 leaders launched the global alliance. today, 21 years later scenes by far best to leave the pandemic behind us. without a truly global immunization campaign, will soon run out of letters in the greek alphabet for new variants of the virus. the good news is, thanks to corporation we have the tools to break the cycle and germany already the second largest loan or a donor to the campaign will continue to do its part by supporting kovacs we are determined to reach 70% of the world population by the middle of the year. and as part of our current g7 presidency will focus on improving the international health infrastructure including countries of the global south. however, we need partners to join hands particularly in the private sector. so in the spirit let us work together to fully fund the global campaign

two german researchers invented a vaccine based on the new mrna technology that saved millions of lives around the world. these examples are proof on the power of cooperation. they talk about exchanges like the one we are having here today. it was in davos in 2000 that the leaders launched the global vaccine alliance. today, 21 years later vaccines are by far our best tool to leave the pandemic behind us. without a truly global immunization campaign we will soon run out of letters in the greek alphabet for new variants of the virus but the good news is, thanks to farsighted cooperation we can break the cycle. germany, already the second largest donors to the global vaccine campaign will continue to do its part by supporting co-that we are determined to reach 70% of the world population by the middle of the year and we will focus on improving the international health infrastructure including in countries of the global south. however, we need partners to join hands particularly in the private sector. to fully fund the global vaccination campaign that would also be the booster shot our eco

they don't so far have the mrna vaccine.e lockdowns which are brutal, the chinese lockdowns are very different from the u.s. lockdowns, you literally can't leave your apartment in the entire city and you have to eat at home and -- so should they be instead allowing, you know, omicron to kind of gradually spread? what would you do? >> so, fareed, yes, we have to contrast. the lockdowns we experienced in the united states and europe are nothing like the chinese. you are in your apartment, they shut off the elevators, food gets delivered to you or it doesn't get delivered to you in some cases and there are draconian measures if you're caught outside and that lasts weeks, it can last more than three weeks of that, and it's millions of people, 14, 15 million people at a time, and many -- in fact, most all the businesses are closed. what they have to do, and you can see this in other countries that adopted initially a zero covid policy, but now are opening up, is you have to vaccinate your population with an effective vaccine, tha

if you look at the two-dose mrna-containing vaccine, all the data published by the cdc in this country is that provides excellent protection against serious disease. what that third dose gives you is much better protection against mild disease for a few months. but is that the long-term public health strategy we're going to try to continue to protect against mild disease, knowing that a two-dose mrna vaccine is enough to protect against severe disease for as long as we've had severe vaccines out there? i think the booster story is some level of detour, if we are really getting on top of this pandemic, we have to vaccinate the unvaccinated. that's the problem. certainly anyone who works in a hospital will tell you that. when we see children coming into the hospital who are over five and could be vaccinated, they're not. nor are their parents nor their siblings. this is a serious disease of the unvaxx cci unvaccinated. it's a mild disease for many, but serious for the unvaccinated. >> we're almost at the year point, and we've been talking about how to convince those unvaccinated folks to

the fact that we have, for example, mrna vaccines and vaccinated millions and millions of people in a short period of time, that's a triumph of science. but one thing to keep in mind, jake, as exciting as the science is, not just for a pan coronavirus vaccine but also for combining a potential flu vaccine and a covid vaccine to reduce the number of shots people get, as exciting as these possibilities are, the benefits of science can only be extended to people if they have accurate information about vaccines and other products of science. one of the worries i have is if we're not simultaneously working on trying to root out misinformation and elevate and uplift accurate information and accurate messengers, then i worry a lot of the benefits that may come in the years ahead may not be accessible to people. >> when is a realistic timeline when americans could get one of the universal coronavirus vaccines should they be discovered? >> well, i don't think we're looking at something this calendar year. it probably would take on the order of several years for something like that to be develo

what we do for moderna to begin more affordable is we are working on a vaccine using mrna to combinend covid into one booster that people like high-risk medical workers, immunocompromised, people with cancer, they can have one in the winter and don't get sick. alix: when do we get data on that? stephane: we have data on flu already, or flu vaccine phase i, the best vaccine that is already on the market today, and we have several ideas on how to keep improving vaccine efficacy. fall 2023 would be the earliest. guy: what is happening with transmission at the moment, and one impact -- and what impact are the vaccines having on transmission, particularly omicron? there's a huge debate about vaccine mandates, particularly in the united states. the argument surrounding those mandates is that it reduces transmission, that it helps society at large. do using the current round of vaccines are delivering that when it comes to omicron? stephane: it is very clear from the data, and i think the data out of the u.k. is the most telling because you were ahead of the u.s. in terms of omicron, the ef